Masaya Tachibana
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 28, 2025
Response to Comment on "Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma".Hiroyuki Inoue, Xiaoning Wang, Ramon Garcia
|Nov 19, 2025
Concentration-QTc Analysis of Valemetostat in Patients With Hematologic Malignancies.Masaya Tachibana, Bill Poland, Yasuyuki Kakurai
|Oct 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.Masaya Tachibana, Steven Horwitz, Eric Jacobsen
|Oct 13, 2025
Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A/P-gp Modulators.Akiko Watanabe, Noriko Okudaira, Masaya Tachibana
|Sep 06, 2025
Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.Hiroyuki Inoue, Xiaoning Wang, Ramon Garcia
|Jul 07, 2025
Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants.Masaya Tachibana, Shunji Matsuki, Akifumi Kurata
Pageof 1
Frequent Collaborators
2 joint publications
Yvonne Lau
2 joint publications
Yasuyuki Kakurai
1 joint publications
Shunji Matsuki
1 joint publications
Masato Fukae
1 joint publications
Akiko Watanabe
1 joint publications
Steven Horwitz
1 joint publications
Eric Jacobsen
1 joint publications
Francine Foss
1 joint publications
Claire Li
1 joint publications
Pierluigi Porcu
